Advertisement
Canada markets closed
  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CAD/USD

    0.7316
    -0.0007 (-0.09%)
     
  • CRUDE OIL

    83.68
    +0.11 (+0.13%)
     
  • Bitcoin CAD

    87,337.10
    -1,282.71 (-1.45%)
     
  • CMC Crypto 200

    1,331.44
    -65.09 (-4.66%)
     
  • GOLD FUTURES

    2,348.30
    +5.80 (+0.25%)
     
  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     
  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6839
    +0.0018 (+0.26%)
     

New Strong Buy Stocks for May 13th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Atlantic Power Corporation (AT): This independent electric power producer has seen the Zacks Consensus Estimate for its current year earnings increasing 87.5% over the last 30 days.

Atlantic Power Corporation Price and Consensus

 

Atlantic Power Corporation Price and Consensus
Atlantic Power Corporation Price and Consensus

Atlantic Power Corporation price-consensus-chart | Atlantic Power Corporation Quote

Loma Negra Compania Industrial Argentina SA (LOMA): This cement manufacturer has seen the Zacks Consensus Estimate for its current year earnings increasing 2.3% over the last 60 days.

Loma Negra Compania Industrial Argentina SA Sponsored ADR Price and Consensus

 

Loma Negra Compania Industrial Argentina SA Sponsored ADR Price and Consensus
Loma Negra Compania Industrial Argentina SA Sponsored ADR Price and Consensus

Loma Negra Compania Industrial Argentina SA Sponsored ADR price-consensus-chart | Loma Negra Compania Industrial Argentina SA Sponsored ADR Quote

ADVERTISEMENT

Puma Biotechnology Inc (PBYI): This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 27.7% over the last 60 days.

Puma Biotechnology Inc Price and Consensus

 

Puma Biotechnology Inc Price and Consensus
Puma Biotechnology Inc Price and Consensus

Puma Biotechnology Inc price-consensus-chart | Puma Biotechnology Inc Quote

Karuna Therapeutics Inc (KRTX): This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 22% over the last 60 days.

Karuna Therapeutics Inc Price and Consensus

 

Karuna Therapeutics Inc Price and Consensus
Karuna Therapeutics Inc Price and Consensus

Karuna Therapeutics Inc price-consensus-chart | Karuna Therapeutics Inc Quote

Livongo Health Inc (LVGO): This consumer digital health company has seen the Zacks Consensus Estimate for its current year earnings increasing 22.2% over the last 60 days.

Livongo Health Inc Price and Consensus

 

Livongo Health Inc Price and Consensus
Livongo Health Inc Price and Consensus

Livongo Health Inc price-consensus-chart | Livongo Health Inc Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

The Hottest Tech Mega-Trend of All                

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Puma Biotechnology Inc (PBYI) : Free Stock Analysis Report
 
Livongo Health Inc (LVGO) : Free Stock Analysis Report
 
Loma Negra Compania Industrial Argentina SA Sponsored ADR (LOMA) : Free Stock Analysis Report
 
Karuna Therapeutics Inc (KRTX) : Free Stock Analysis Report
 
Atlantic Power Corporation (AT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research